CytoReason, a leader in developing computational disease models for predictive insights, announced it secured an aggregated $80 million from OurCrowd, NVIDIA, Pfizer, and Thermo...
Certara, Inc., a global leader in model-informed drug development, announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics...
Certara, Inc., a global leader in model-informed drug development, unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical...
PhenoScope can cut drug development time and costs significantly, while delivering safer & more effective therapy for cancer patients
SimBioSys, a leading innovator in precision...
Intelligencia AI, a provider of AI-powered solutions that support data-driven decision-making in drug development, announced that the U.S. Patent and Trademark Office (USPTO) issued...
BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and...